Molecular formula:C43H67N11O12S2
Molecular weight: 994.19 g·mol−1
Patent period: —
Dositive specifications:–
Injection :–
Oral tablets: —
Injection: —
Molecular formula:C43H67N11O12S2
Molecular weight: 994.19 g·mol−1
Patent period: —
Dositive specifications:–
Injection :–
Oral tablets: —
Injection: —
Atosiban is a peptide Oxytocin Receptor Inhibitor. Atosiban is a nonapeptide, desamino-oxytocin analogue, and a competitive vasopressin/oxytocin receptor antagonist (VOTra). Atosiban inhibits the oxytocin-mediated release of inositol trisphosphate from the myometrial cell membrane. As a result, reduced release of intracellular, stored calcium from the sarcoplasmic reticulum of myometrial cells and reduced influx of Ca2+ from the extracellular space through voltage-gated channels occur. In addition, atosiban suppresses oxytocin-mediated release of PGE and PGF from the decidua.
Catalog Num | A14334 |
---|---|
CAS NO. | 90779-69-4 |
FORMULA | C43H67N11O12S2 |
M. WT | 994.2 |
PURITY | — |
SMILES | CC[C@H](C)[C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CSSCCC(=O)N[C@@H](C(=O)N1)CC2=CC=C(C=C2)OCC)C(=O)N3CCC[C@H]3C(=O)N[C@@H](CCCN)C(=O)NCC(=O)N)CC(=O)N)[C@@H](C)O |
STORAGE | Store lyophilized at -20ºC, keep desiccated. In lyophilized form, the chemical is stable for 36 months. In solution, store at -20ºC and use within 3 months to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles. |